has selected XIFAXAN® (rifaximin) 550 mg tablets as one of the medicines for the second round of negotiation as part of the Inflation Reduction Act with an initial price applicability in 2027 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback